Title |
Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
|
---|---|
Published in |
PLOS ONE, May 2013
|
DOI | 10.1371/journal.pone.0062778 |
Pubmed ID | |
Authors |
Timothy J. Powell, Yanchun Peng, Tamara K. Berthoud, Marie-Eve Blais, Patrick J. Lillie, Adrian V. S. Hill, Sarah L. Rowland-Jones, Andrew J. McMichael, Sarah C. Gilbert, Tao Dong |
Abstract |
Current influenza vaccines stimulate neutralising antibody to the haemagglutinin antigen but as there is antigenic drift in HA it is difficult to prepare a vaccine in advance against an emergent strain. A potential strategy is to induce CD8(+) and CD4(+) T cells that recognize epitopes within internal proteins that are less subject to antigenic drift. Augmenting humoral responses to HA with T cell responses to more conserved antigens may result in a more broadly protective vaccine. In this study, we evaluate the quality of influenza specific T cell responses in a clinical trial using MVA-NP+M1 vaccination followed by influenza virus challenge. In vaccinated volunteers, the expression of Granzyme A, Perforin and CD57 on influenza HLA A*02 M158-66 antigen specific cells was higher than non-vaccinated volunteers before and after challenge despite a similar frequency of antigen specific cells. BCL2 expression was lower in vaccinated volunteers. These data indicate that antigen specific T cells are a useful additional measure for use in human vaccination or immunization studies. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 3% |
United States | 1 | 1% |
Russia | 1 | 1% |
Unknown | 76 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 21 | 26% |
Researcher | 21 | 26% |
Student > Master | 9 | 11% |
Student > Bachelor | 8 | 10% |
Student > Doctoral Student | 5 | 6% |
Other | 8 | 10% |
Unknown | 8 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 21 | 26% |
Medicine and Dentistry | 17 | 21% |
Immunology and Microbiology | 14 | 18% |
Biochemistry, Genetics and Molecular Biology | 9 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 5 | 6% |
Unknown | 12 | 15% |